Biomea Fusion Future Growth
Future criteria checks 2/6
Biomea Fusion is forecast to grow earnings and revenue by 11.3% and 85.4% per annum respectively. EPS is expected to grow by 10.1% per annum. Return on equity is forecast to be -126.6% in 3 years.
Key information
11.3%
Earnings growth rate
10.1%
EPS growth rate
Biotechs earnings growth | 28.2% |
Revenue growth rate | 85.4% |
Future return on equity | -126.6% |
Analyst coverage | Good |
Last updated | 29 Aug 2024 |
Recent future growth updates
Recent updates
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully
Jun 10We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth
Feb 22Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?
Nov 07We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully
Jul 12Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
Mar 29We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely
Nov 03Biomea Fusion GAAP EPS of -$0.59 beats by $0.01
Aug 01We're Not Very Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Jul 20Biomea Fusion (NASDAQ:BMEA) Is In A Good Position To Deliver On Growth Plans
Mar 16Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
Nov 27Biomea Fusion: Patience Warranted
Sep 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3 | -169 | -165 | -134 | 7 |
12/31/2025 | 2 | -150 | -157 | -119 | 7 |
12/31/2024 | N/A | -147 | -145 | -120 | 7 |
6/30/2024 | N/A | -140 | -112 | -111 | N/A |
3/31/2024 | N/A | -127 | -105 | -105 | N/A |
12/31/2023 | N/A | -117 | -100 | -97 | N/A |
9/30/2023 | N/A | -108 | -98 | -94 | N/A |
6/30/2023 | N/A | -102 | -91 | -87 | N/A |
3/31/2023 | N/A | -95 | -80 | -76 | N/A |
12/31/2022 | N/A | -82 | -63 | -62 | N/A |
9/30/2022 | N/A | -71 | -59 | -58 | N/A |
6/30/2022 | N/A | -61 | -53 | -50 | N/A |
3/31/2022 | N/A | -52 | -45 | -41 | N/A |
12/31/2021 | N/A | -42 | -39 | -35 | N/A |
9/30/2021 | N/A | -30 | -25 | -22 | N/A |
6/30/2021 | N/A | -19 | -15 | -14 | N/A |
3/31/2021 | N/A | -11 | -8 | -8 | N/A |
12/31/2020 | N/A | -5 | -5 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BMEA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BMEA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BMEA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BMEA's revenue (85.4% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: BMEA's revenue (85.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BMEA is forecast to be unprofitable in 3 years.